Trilogy Evo
K-Number: K181166 · 2019-07-18
ApplicantRespironics, Inc.
Decision Date2019-07-18
Product CodeCBK
Advisory CommitteeAN
DecisionSubstantially Equivalent
Device Summary
Trilogy Evo is a medical device manufactured by Respironics, Inc.. It received FDA 510(k) clearance on 2019-07-18 under approval number K181166. The device is classified under product code CBK. It was reviewed by the AN advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the Trilogy Evo?
Trilogy Evo is a medical device that received FDA 510(k) clearance on 2019-07-18. It is manufactured by Respironics, Inc.. The 510(k) number is K181166.
When was Trilogy Evo approved by the FDA?
Trilogy Evo received FDA 510(k) clearance on 2019-07-18, under approval number K181166.
What company makes Trilogy Evo?
Trilogy Evo is manufactured by Respironics, Inc..
What is the FDA product code for Trilogy Evo?
The FDA product code for Trilogy Evo is CBK.
Other Devices by Respironics, Inc.
Related Devices (Code: CBK)
K153046HAMILTON-MR1Hamilton Medical AG
K152068Astral 100/150Resmed, Ltd.
K143035Flight 60 VentilatorFlight Medical Innovations , Ltd.
K151252Puritan Bennett 840 Series Ventilator SystemCovidien LP
K162738Puritan Bennett 980 Ventilator SystemCovidien
K170037Breathe Technologies Life2000 Ventilation SystemBreathe Technologies
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.